NOVARA MARK DAVID (EVP & CHIEF COMMERCIAL OFFICER) received a stock award from TANDEM DIABETES CARE INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/19/2025ACC: 0001438133-25-000089
Officer· EVP & CHIEF COMMERCIAL OFFICER
Since Mar 2026
+757.00
Net shares
Net buyer
$2.6K
Total sold
0
Open market trades
0B · 0S
4
Total transactions
1.17K acquired · 417.00 disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+870.00
Price / share
$19.30
Trade value
$16.79K
% of position
3.6%
5/15/2025
24.13K→25K
Common Stock
Direct
Shares
+304.00
Price / share
—
Trade value
—
% of position
1.2%
5/15/2025
25K→25.31K
Common Stock
Direct
Shares
−113.00
Price / share
$22.70
Trade value
$2.57K
% of position
0.4%
5/15/2025
25.31K→25.20K
Total
Net shares
+1.06K
Net value
$14.23K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/15/2025 | A · Award | +870.00 | $19.30 | $16.79K | 3.6% | 24.13K | 25K |
| Common Stock Direct | 5/15/2025 | M · Option Exercise | +304.00 | — | — | 1.2% | 25K | 25.31K |
| Common Stock Direct | 5/15/2025 | F · Tax Withholding | −113.00 | $22.70 | $2.57K | 0.4% | 25.31K | 25.20K |
| Total | +1.06K | $14.23K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
304.00 shares
Shares
−304.00
Strike price
Held after
609.00
Exercisable
—
5/15/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock304.00 shares | 5/15/2025 | M · Option Exercise | −304.00 | — | 609.00 |